Skip to main content
. 2017 Oct 16;8(56):96190–96202. doi: 10.18632/oncotarget.21878

Figure 3. Comparison of progression-free survival curves of esophageal squamous cell carcinoma patients with different tumor locations.

Figure 3

(A) Upper/middle thirds, celiac LN metastasis group versus non-celiac LN metastasis group (B) Lower third, celiac LN metastasis group versus non-celiac LN metastasis group (C) Upper/middle thirds, celiac LN metastasis group versus matched non-celiac LN metastasis group (D) Lower third, celiac LN metastasis group versus matched non-celiac LN metastasis group. LN: lymph node.